financetom
Business
financetom
/
Business
/
BRIEF-Pharmacorp to Acquire Ontario Pharmacy, Eyes Two More in East Canada; Q2 Update Released
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Pharmacorp to Acquire Ontario Pharmacy, Eyes Two More in East Canada; Q2 Update Released
Sep 8, 2025 5:13 AM

Sept 8 (Reuters) - PharmaCorp Rx Inc:

* PHARMACORP TO ACQUIRE A PHARMACY IN ONTARIO FOR

$5,300,000, NEW

NON-BINDING LETTER OF INTENT TO ACQUIRE TWO PHARMACIES IN

EASTERN CANADA, UPDATES ON PREVIOUSLY ANNOUNCED NON-BINDING

LETTERS OF INTENT AND FILING OF Q2 INVESTOR PRESENTATION

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Premarket Gainers
Top Premarket Gainers
Sep 8, 2025
07:36 AM EDT, 09/08/2025 (MT Newswires) -- Rapport Therapeutics ( RAPP ) shares were 165% higher pre-bell Monday after the company said that a phase 2a trial of RAP-219 in patients with drug-resistant focal onset seizures met its primary endpoint. Forward Industries ( FORD ) stock was up 102% after the company said it has secured $1.65 billion for its...
BRIEF-Pharmacorp to Acquire Ontario Pharmacy, Eyes Two More in East Canada; Q2 Update Released
BRIEF-Pharmacorp to Acquire Ontario Pharmacy, Eyes Two More in East Canada; Q2 Update Released
Sep 8, 2025
Sept 8 (Reuters) - PharmaCorp Rx Inc: * PHARMACORP TO ACQUIRE A PHARMACY IN ONTARIO FOR $5,300,000, NEW NON-BINDING LETTER OF INTENT TO ACQUIRE TWO PHARMACIES IN EASTERN CANADA, UPDATES ON PREVIOUSLY ANNOUNCED NON-BINDING LETTERS OF INTENT AND FILING OF Q2 INVESTOR PRESENTATION Source text: Further company coverage: ...
Pfizer, BioNTech Report Positive Preliminary Data From Phase 3 Study for Adapted COVID Vaccine
Pfizer, BioNTech Report Positive Preliminary Data From Phase 3 Study for Adapted COVID Vaccine
Sep 8, 2025
07:36 AM EDT, 09/08/2025 (MT Newswires) -- Pfizer ( PFE ) and BioNTech (BNTX) said Monday that preliminary data from a phase 3 study of their LP.8.1-adapted COVID-19 vaccine, Comirnaty, showed a robust immune response. The cohort included 50 adults aged 65 and older and 50 adults aged 18-64 with at least one underlying risk factor for severe COVID-19. All...
Market Chatter: Meta Selects Pacific Investment for $26 Billion Debt Funding Deal
Market Chatter: Meta Selects Pacific Investment for $26 Billion Debt Funding Deal
Sep 8, 2025
07:37 AM EDT, 09/08/2025 (MT Newswires) -- Meta Platforms ( META ) has selected Pacific Investment Management to lead a $26 billion debt financing to construct a new data center in Louisiana, Bloomberg reported Saturday, citing sources familiar with the matter. Blue Owl Capital (OWL) will contribute $3 billion in equity to a joint venture that will build and own...
Copyright 2023-2026 - www.financetom.com All Rights Reserved